TM
RVMD icon

Torren Management’s Revolution Medicines RVMD Stock Holding History

Torren Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.55K Hold
35
– – ﹤0.01% 272
2026
Q1 		$3.4K Sell
35
-381
-92% -$38.5K ﹤0.01% 408
2025
Q4 		$33.1K Buy
+416
New +$27.3K 0.02% 448

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
MGB
Mass General Brigham Somerville, Massachusetts $361M AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Torren Management's RVMD Position: Q2 2026 in Review

Torren Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 35 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Torren Management first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $33.1K in Q4 2025. 294 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Torren Management held 35 shares of Revolution Medicines worth $6.55K as of Q2 2026.
  • Torren Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #272 holding.
  • Torren Management first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Revolution Medicines position peaked at $33.1K in Q4 2025.
  • 294 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.